Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice.

Abstract

There is no safe and efficacious vaccine against human leishmaniasis available and live attenuated vaccines have been used as a prophylactic alternative against the disease. In order to obtain an attenuated Leishmania parasite for vaccine purposes, we generated L. infantum KHARON1 (KH1) null mutants (ΔLikh1). This gene was previously associated with growth defects in L. mexicana. ΔLikh1 was obtained and confirmed by PCR, qPCR and Southern blot. We also generate a KH1 complemented line with the introduction of episomal copies of KH1. Although ΔLikh1 promastigote forms exhibited a growth pattern similar to the wild-type line, they differ in morphology without affecting parasite viability. L. infantum KH1-deficient amastigotes were unable to sustain experimental infection in macrophages, forming multinucleate cells which was confirmed by in vivo attenuation phenotype. The cell cycle analysis of ΔLikh1 amastigotes showed arrested cells at G2/M phase. ΔLikh1-immunized mice presented reduced parasite burden upon challenging with virulent L. infantum, when compared to naïve mice. An effect associated with increased Li SLA-specific IgG serum levels and IL-17 production. Thus, ΔLikh1 parasites present an infective-attenuated phenotype due to a cytokinesis defect, whereas it induces immunity against visceral leishmaniasis in mouse model, being a candidate for antileishmanial vaccine purposes.

• Authors: Ana Maria Murta Santi, Juliane Sousa Lanza, Luiza Guimarães Tunes, Jacqueline Araújo Fiuza, Gaétan Roy, Alessandra da Silva Orfanó, Andréa Teixeira de Carvalho, Frédéric Frézard, André Luís Branco de Barros, Silvane Maria Fonseca Murta, Rubens Lima do Monte-Neto
• Journal: Scientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 11627 (08 02 2018) ISSN: 2045-2322 [Electronic] England
• PMID: 30072701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Animals
• Cytokinesis (genetics, immunology)
• Disease Models, Animal
• G2 Phase Cell Cycle Checkpoints (genetics, immunology)
• Humans
• Leishmania infantum (genetics, growth & development, immunology)
• Leishmaniasis, Visceral (genetics, immunology, metabolism, prevention & control)
• M Phase Cell Cycle Checkpoints (genetics, immunology)
• Macrophages (immunology, metabolism, parasitology)
• Mice
• Mice, Inbred BALB C
• Mice, Knockout
• Mutation
• Plasmids (genetics, immunology, metabolism)
• THP-1 Cells